| Title | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome |
|---|---|
| Disease/Condition | Heart and Vascular Diseases,Cardiology,Radiology |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Anna Bortnick, MD |
| Contact Name | Roy Park |
| Contact Email | rpark@montefiore.org |
| IRB/Protocol Number | 18-02-89-01 |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Cardiology |